Related Experiment Video
Updated: Jul 5, 2026

Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug
Published on: December 14, 2021
Pharmacokinetics and tissue distribution of anidulafungin in rats
Bharat Damle1, Martin Stogniew, James Dowell
1Pfizer Inc., New York, New York 10017, USA. bharat.damle@pfizer.com
Abstract:
This study assessed the tissue distribution of anidulafungin in rats. Anidulafungin rapidly distributed into tissues, achieving peak concentrations within 30 min, and maintained levels above MICs for common pathogens over 72 h. In tissues susceptible to fungal infection (liver, lung, spleen, kidney), exposure was 9- to 12-fold higher than in plasma.
Insights
Anidulafungin distributes rapidly into rat tissues, maintaining antifungal levels for over 72 hours. Key organs like the liver and lungs showed significantly higher drug exposure compared to plasma.
Area of Science:
- Pharmacology
- Mycology
- Drug Metabolism and Distribution
Background:
- Anidulafungin is an echinocandin antifungal agent.
- Understanding tissue distribution is crucial for optimizing antifungal therapy.
- Fungal infections require effective drug concentrations at infection sites.
Purpose of the Study:
- To evaluate the pharmacokinetic profile and tissue distribution of anidulafungin in a rat model.
- To determine the duration of effective anidulafungin concentrations in various tissues.
Main Methods:
- Anidulafungin was administered to rats.
- Tissue and plasma samples were collected at various time points.
- Drug concentrations were quantified using validated analytical methods.
Main Results:
- Anidulafungin exhibited rapid tissue distribution, reaching peak concentrations within 30 minutes.
- Antifungal concentrations remained above the minimum inhibitory concentrations (MICs) for common fungal pathogens for over 72 hours.
- Exposure in infection-susceptible tissues (liver, lung, spleen, kidney) was 9- to 12-fold higher than in plasma.
Conclusions:
- Anidulafungin demonstrates favorable tissue penetration and prolonged retention in rats.
- High drug exposure in key organs suggests potential efficacy against systemic fungal infections.
- These findings support the clinical utility of anidulafungin in treating invasive fungal diseases.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
06:53An Optimized Protocol for Candida albicans Infection in Schmidtea mediterranea to Study Fungal Pathogenesis and Host Defense
Published on: April 17, 2026
Related Concept Videos
Pharmacodynamic Models: Overview
Estimation of k and VD of Aminoglycosides
Drug Distribution: Tissue Binding
For...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Measurement of Bioavailability: Pharmacokinetic Methods
Factors Affecting Drug Distribution: Organ Perfusion Rate
Perfusion rate-limited distribution relies on the...